Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma × Clozapine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Urinary Tract Infections 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Pain 1 Neutropenia 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Lymphoma 1 Leukemia 1 Intraabdominal Infections 1 Influenza, Human 1 Inflammation 1 Infections 1 Hypokalemia 1 Hypertension 1 Hyperaldosteronism 1 Herpes Simplex 1 Hemophilia A 1 Hemangioma, Capillary 1

Interventions

Cyclophosphamide 272 Rituximab 243 Etoposide 136 Filgrastim 128 fludarabine phosphate 105 Cytarabine 98 Vincristine 97 Radiotherapy 96 Melphalan 95 Doxorubicin 90 Peripheral Blood Stem Cell Transplantation 82 Methotrexate 80 fludarabine 78 Prednisone 78 Busulfan 77 Tacrolimus 54 Whole-Body Irradiation 52 Mycophenolic Acid 52 Granulocyte Colony-Stimulating Factor 52 Dexamethasone 52 Antilymphocyte Serum 51 Carmustine 49 Cyclosporine 39 Lenalidomide 38 Methylprednisolone 37 Bortezomib 37 Bendamustine Hydrochloride 34 sargramostim 33 Stem Cell Transplantation 31 Ifosfamide 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04074213 2019-08-30

CLOZARIX

University Hospital, Caen

1,000,000 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡